This is the second tutorial where we dive into advanced features of ocw workflows. Check-out the basics tutorial to get an overview of ocw. Make sure you have the ocw cli and Podman installed to ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Arctic Fox is a custom desktop system project that integrates open-source bootloading technology with Apple's macOS development principles. It is tailored for power users and enthusiasts, ...

Xcode 26.3 unlocks agentic coding. That lets developers harness agents like Anthropic’s Claude Agent and OpenAI’s Codex directly in Xcode. The new Xcode 26.3 release candidate introduces support for ...

Apple has embraced agentic AI for developers, introducing direct support in Xcode 26.3 for both Anthropic’s Claude Agent and OpenAI’s Codex and making vibe coding now a platform feature for iPhone, ...

Xcode 26.3 adds autonomous AI agents inside the IDE. Agents can build, test, and fix compile errors on their own. New visual checks use screenshots, but device limits remain. Apple today introduced a ...

A screenshot of Xcode 26.3 showing the IDE's new Intelligence menu for picking coding agent. (Apple) Apple has just released Xcode 26.3, and it's a big step forward in terms of the company's support ...

Developers can use Anthropic’s Claude Agent and OpenAI’s Codex to take action in Xcode on their behalf. Developers can use Anthropic’s Claude Agent and OpenAI’s Codex to take action in Xcode on their ...

Apple is bringing agentic coding to Xcode. On Tuesday, the company announced the release of Xcode 26.3, which will allow developers to use agentic tools, including Anthropic’s Claude Agent and ...

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic ...